Skip to main content
Premium Trial:

Request an Annual Quote

Irene Sun, Robert Johnson, Hana Moran, H. Lee Sweeney


Irene Sun, a 16-year-old from Indianapolis, has received a $25,000 Davidson Institute fellowship for her project, “Model-based Gene Expression Analysis of Synovial Cells Under Impulsive Shock.” The high school senior, who will enter Harvard University this fall, was one of 15 young scholars presented as Davidson Institute fellows, an annual coronation of some of the country’s brightest students. The 15 scholars receive fellowships ranging from $10,000 to $50,000 from the Reno, Nev.-based non-profit organization.


Robert Johnson has been named president and chief operating officer of Spectral Genomics, the Houston-based microarray company said last week. Johnson was most recently chief operating officer and chief scientific officer at VitaGen, a cell therapy company. Prior to that, he was senior research director of the gene therapy business unit at Baxter Healthcare, where he worked for 18 years.


Hana Moran joins Nuvelo as vice president of regulatory affairs and quality assurance, the company said last week. Moran comes to Nuvelo from Lipid Sciences, where she was vice president of regulatory affairs and quality assurance. Before that she held senior management positions at BioMedicines and SangStat Medical. From 1983 to 1994, Moran served in various regulatory affairs and quality-assurance roles at companies including Athena Neurosciences, Fujisawa Pharmaceutical, Boehringer-Ingelheim, and G.D. Searle.


H. Lee Sweeney joins the scientific advisory board of PTC Therapeutics. Sweeney is professor and chairman of physiology at the University of Pennsylvania School of Medicine. He is also a member of the board of scientific counselors of the National Institute of Arthritis, Musculoskeletal and Skin Diseases of the National Institute of Health; the scientific director for the Parent Project Muscular Dystrophy organization; and is a member of the Translational Research Advisory Committee for the Muscular Dystrophy Association.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.